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Abstract 
Our group has identified Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR) as a tumor suppressor for colorectal cancer (CRC) (Than et al., 
2016). However, the mechanism by which CFTR protects against CRC is unknown. 
Determining this mechanism may lead to new therapies for CRC. Gene Set 
Enrichment Analysis (GSEA) pathway analysis showed that CFTR-deficient normal 
and tumor tissues from mice and humans were enriched in genes involved in the 
unfolded protein response (UPR) to endoplasmic reticulum (ER) stress. Altered genes, 
environmental stress and increased protein synthesis induce UPR activation in cancer 
cells (Kaufman & Wang, 2014; Ma & Hendershot, 2004; Dejeans, Barroso, 
Fernandez-Zapico, Samali, Chevet, 2015). The UPR has two potentially opposing 
effects on cancer development: on the one hand, some cancer cells require a higher 
level of UPR to support their growth and survival (Corazzari, Gagliardi, Fimia & 
Piacentini, 2017); on the other hand, increased UPR leads to loss of stemness which 
could inhibit cancer development (Heijmans et al., 2013). To identify the correlation 
between UPR and cancer-supporting effects of CFTR-deficiency, a pair of CFTR 
knockout (KO) and wildtype (WT) Caco2 cell lines created by CRISPR-Cas9 
engineering were utilized to test the working model that UPR activation might be 
enhanced in CFTR KO cells, and this activation might support CRC cell survival 
under ER stress. To test the working model, the Caco2 cell lines were treated with 
chemical inducers to trigger ER stress. To evaluate the UPR activities, we used 
Thapsigargin (TG) to induce ER stress in CFTR KO and WT cell lines and compared 
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mRNA expression changes of key genes in the two cell lines by performing RT-
qPCR. The heat shock protein A member 5 (HSPA5) gene encodes the protein that 
initiates all three UPR sub-pathways. Although the expression of HSPA5 increased 
after TG treatment in both CFTR WT and CFTR KO cell lines, the TG treatment had 
more of an effect on HSPA5 expression in CFTR KO cells, suggesting a trend that 
CFTR deficiency might enhance the effect of ER stress on the expression of UPR 
gatekeeper HSPA5, the common regulator for initiating three UPR sub-pathways. The 
ATF4 expression levels in both CFTR WT and CFTR KO cell lines increased to the 
same extent, which reflects that the loss of CFTR might not promote the activation of 
PERK signaling. The decreased total XBP1 mRNA expression levels in CFTR KO 
cells suggests that CFTR deficiency might not activate the specific IRE1α-XBP1 
signaling pathway. The TXNIP, which is part of an apoptotic pathway, is down-
regulated in CFTR KO cells, which might provide protection from apoptosis. These 
studies suggest that UPR activation might be enhanced in CFTR KO cells, but the 
specific pathway might not be the one detected. Additionally, the down regulation of 
TXNIP might offer protection for CRC cells from apoptosis.  
Although many cancer cells require an enhanced UPR (Corazzari, Gagliardi, Fimia & 
Piacentini, 2017), excessive, prolonged activation triggers a switch to an apoptotic 
pathway (Wang & Kaufman, 2016; Niederreiter, L. et al., 2013). To examine this 
possibility, TG and Tunicamycin (TM) were used to induce ER stress in cells, and cell 
viability in CFTR KO and WT cell lines over time was compared by conducting MTT 
assay. Although the results showed decreased cell viability after treatment in both 
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CFTR WT and CFTR KO cell lines, the ratios of treated over untreated viability at 
each point after TG and TM treatment was higher in CFTR KO cells, indicating that 
the loss of CFTR might cause TG-induced ER stress to have less of an effect on cell 
viability. These data suggest that the loss of CFTR increases protection from ER 
stress, and that this protection supports the survival of CRC cells.  
Based on the fact that CFTR deficiency can activate the NF-κB signaling pathway 
(Crites et al., 2015), and that UPR can activate the NF-κB (Grootjans, Kaser, 
Kaufman & Blumberg, 2016), the NF-κB activity in CFTR KO cells in response to 
UPR was also examined. RT-qPCR analysis was performed to compare the gene 
expression changes relating to NF-κB signaling pathway in CFTR WT and CFTR KO 
Caco2 cell lines treated with TG to trigger UPR activation. Although the results 
showed enhanced expression of IL8 and TNF in both cell lines, the TG treatment had 
less of an effect on the expression of these genes in CFTR KO cells. This suggests that 
CFTR deficiency might cause TG to produce less of an effect on the expression of 
NF-κB signaling target genes IL8 and TNF. These data suggest that the loss of CFTR 
might cause TG-induced UPR to have less of an effect on NF-κB activation. The 
enhanced basal expression levels of the NF-κB target gene IL8 in CFTR KO cells 
might suggest an increased activation of NF-κB signaling in CFTR KO cells and this 
activation might support the growth of cancer cells.  
In conclusion, in Caco2 CRC cells, CFTR deficiency may alter the response to UPR in 
several pathways, which may promote cancer cell survival. Additional experiments 
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must be conducted to determine which pathways among those that are altered are vital 
for cancer development.  
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Introduction 
Colorectal Cancer 
Colorectal cancer (CRC) is the third leading cause of cancer deaths all over the 
world (Rosa et al., 2015). It is estimated that in 2018, about 50,630 people will die of 
colorectal cancer in the US (The American Cancer Society, 2018). Colorectal cancer 
starts in the large intestine or rectum (Heath, 2010). If you observe a cross section of a 
colon from the inside out, the layer closet to the lumen is called the mucosa, which is 
composed of epithelium, lamina propria, and muscularis mucosae (Figure 1; Heath, 
2010). The intestinal epithelium is structured as a simple columnar epithelium layer 
containing millions of “crypts of Lieberkuhn” that are goblet-shaped invaginations of 
the epithelium into the underlying connective tissue (Clevers, 2013; Heath, 2010). 
Benign tumors, or adenomas, start in epithelial cells and remain in the mucosal layer 
(Fearon et al., 2011; Vogelstein, 1988). Adenomas can be detected through 
colonoscopy and surgically removed, and tumors cells will not likely grow back 
(Billings et al., 2014; Zauber et al., 2012). However, when tumor cells invade the 
submucosa layer, they form carcinomas (Fearon et al., 2011; Vogelstein, 1988). These 
carcinomas are malignant and invade local and adjacent tissues (Fearon & Vogelstein, 
1990). When malignant tumor cells travel to distant places in the body through the 
blood or the lymph system and form new tumors far from the original tumor, metastasis 
occurs (Martin, Ye, Sanders, Lane & Jiang, 2013). These metastatic cancer cells can 
damage important organs and cause death. In order to cure CRC, it is important to 
focus on its biology. 
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Figure 1. Organization of the intestine (Heath, 2010). 
  
Intestinal Epithelial Cells 
CRC starts in the intestinal epithelium, so concentrating on intestinal epithelial 
cells is necessary for the investigation into the biology of CRC. An intestinal stem cell 
generates a new stem cell and a transit-amplifying cell which cycles a limited number 
of times before differentiation (Clevers, 2013). The differentiated progeny cells include 
enterocytes, goblet cells, entero-endocrine cells, and Paneth cells (absent in the colon) 
(Clevers, 2013). 
APC and Wnt/ β-catenin 
Over 80% of colorectal cancer originates from mutations in a tumor suppressor 
gene called adenomatous polyposis coli (APC) (Brannon et al., 2014; Vogelstein & 
Kinzler, 1996). APC proteins control cell proliferation within the colon through 
regulating the conserved Wnt/β-Catenin pathway, which determines cell fate during 
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development (Clevers & Nusse, 2012). The APC protein resides in the destruction 
complex, together with the tumor suppressor proteins Axin and WTX and two 
constitutively active serine-threonine kinases (Li et al., 2012). The destruction complex 
phosphorylates and ubiquitinates β-catenin by β-TrCP, and β-catenin is degraded by a 
proteasome (Li et al., 2012; Clevers & Nusse, 2012). Intestinal stem cells located at the 
base of the crypt receive Wnt signals from stromal cells (Figure 2; Wetering et al., 
2002). The binding of Wnts to the cell surface receptors saves the β-catenin from the 
degradation. The β-catenin migrates to the nucleus where it replaces the transcription 
repressor Groucho on TCF transcription factors to cause the transcription of Wnt target 
genes (Cavallo et al., 1998; Clevers & van der Flier, 2009). The β-catenin/TCF 
complex inhibits cell differentiation and maintains cell proliferation, which is important 
for maintaining the intestinal proliferative compartment (Wetering et al., 2002). Stem 
cell progenies move upward toward the lumen of the intestine and will not receive 
enough Wnt signals, leading to the degradation of β-catenin by a proteasome. The 
degradation of β-catenin will cause decreased cell proliferation and increased 
differentiation. When the APC protein is defective, the β-catenin will escape from the 
degradation, contributing to cell proliferation even in the absence of the Wnt signal. As 
a result, undifferentiated cells fail to move upward; instead they accumulate within the 
crypt and eventually form polyps.  
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Figure 2. Model for the role of APC and Wnt/ β-catenin in the early stages of 
intestinal tumorigenesis (Wetering et al., 2002). 
 
Cancer Stem Cells 
It is believed that a minority of tumor cells, termed cancer stem cells (CSC), are 
responsible for tumor growth and spread (Khalek, Gallicano & Mishra, 2010). CSC are 
defined because they have characteristics similar to normal stem cells. They have self-
renewal capacities that drive tumorgenesis and the property to aberrantly differentiate 
and generate the bulk of cells within a tumor (Khalek, Gallicano & Mishra, 2010). 
CRC is believed to initiate from the transformation of intestinal stem cells that have 
undergone oncogenic mutations. Leucine rich repeat containing G protein coupled 
receptor 5 (Lgr5) is an intestinal stem cell signature gene because it is expressed 
exclusively in the cycling columnar cells at the intestinal crypt base where intestinal 
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stem cells are located (Barker et al., 2007). The Lgr5-positive crypt base columnar cells 
have the stem cell capacity to generate all intestinal epithelial lineages (Barker et al., 
2007). Stem cell-specific Apc deficiency induces intestinal adenoma in mice. Apc 
deficiency in Lgr5-positive crypt base columnar cells causes transformation of stem 
cells and maintenance at the crypt base to support the growth and development of 
adenoma in mice (Barker et al., 2009).  
Molecular Genetics of Colorectal Cancer  
Mutations in APC lead to the accumulation of polyps or benign adenomas from 
which most colorectal cancers develop, but additional genetic alterations are required to 
cause invasive carcinomas (Fearon & Vogelstein, 1990; Clevers & van der Flier, 2009). 
Molecular alterations that allow the progression from adenomatous polyps to colorectal 
cancer might include the activation of oncogenes coupled with deficiencies of tumor 
suppressors. For example, the subsequent mutations in p53, KRAS and other genes that 
follow the formation of adenomas allow tumors to develop and become malignant and 
even metastatic (Dow et al., 2015; Fearon & Vogelstein, 1990; Clevers & van der Flier, 
2009). However, CRC is different in each patient. The accumulation of more than six 
gene mutations may be required to develop colorectal cancer (Calabrese et al., 2005).  
Desire for Identification of Other Drivers for Colorectal Cancer 
To cure CRC, knowledge about mutations in main drivers, such as in APC, is 
currently insufficient. It is thus important to identify other genetic alterations required 
for CRC development. Understanding the full set of mutations in each patient’s cancer 
and how these mutations affect the behavior of the cancer makes it possible for each 
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patient to receive precision medicine and better medical care. Not all of the altered 
genes in CRC patients are drivers for colorectal cancer. To identify genes that, when 
altered, would contribute to causing CRC, Sleeping Beauty (SB) transposon-based 
screens were conducted by Dr. Robert Cormier, Dr. David Largaespada and Dr. 
Timothy Starr at the University of Minnesota (Starr et al. 2009; Starr et al. 2011). 
These researchers introduced random insertional mutations in mice through a synthetic 
DNA transposon and then determined if these mutations caused intestinal tumors (Starr 
et al. 2009; Starr et al. 2011).  
Cystic Fibrosis Transmembrane Conductance Regulator 
Dr. Robert Cormier, Dr. David Largaespada and Dr. Timothy Starr identified 77 
novel candidate genes for CRC, and 60 among these 77 candidate genes were 
dysreglated in human CRC (Starr et al. 2009). Among these 60 candidate drivers for 
human and murine CRC, the Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR) was determined to be a common insertion site candidate CRC gene in multiple 
SB transposon-based mutagenesis screens in mouse intestines (Starr et al., 2009). 
CFTR is a chloride ion channel gene that plays a crucial role in homeostasis of various 
epithelia, especially in the intestine where it maintains chloride and bicarbonate 
secretion and fluid homeostasis (De Lisle & Borowitz, 2013). The CFTR gene is highly 
expressed in the mucosa of the intestine, with a decreasing gradient of expression along 
the base of the crypt to the tip axis. Mutations in the CFTR gene lead to cystic fibrosis, 
the most common autosomal recessive disorder in Caucasians (Cystic Fibrosis 
Foundation Patient Registry, as cited in Crites et al., 2015). Cystic fibrosis (CF) leads 
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to impaired chloride ion channel function and dysregulation of the epithelial fluid 
transport (De Lisle & Borowitz, 2013). Particularly in the mucosa of the intestine, 
impaired chloride ion channel function causes incomplete clearance and thick mucus, 
creating an environment for abnormal microbial colonization which can lead to 
microbial dysbiosis. 
The Relationship between Cystic Fibrosis and Colorectal Cancer 
A 20-year nationwide study has found an increased risk of digestive tract cancers, 
including small intestinal and colorectal cancer, in CF patients (Maisonneuve, 
Marshall, Knapp & Lowenfels, 2012). A study conducted by the Minnesota Cystic 
Fibrosis Center analyzed the results of colonoscopies after age 40 (Niccum, Billings, 
Dunitz & Khoruts, 2016). More than 50% of CF patients had adenomatous polyps, and 
about 25% of them had advanced adenomas. Early and high incidences of adenomas 
were found in CF patients.  
Identification of CFTR as a Tumor Suppressor in Human and Murine Colorectal 
Cancer 
To confirm the role of CFTR in colon cancer, our lab has studied CFTR deficiency 
in various mouse models and in human CRC patients. In 2016, our lab published that 
CFTR is a tumor suppressor in murine and human CRC (Than et al., 2016). A previous 
member of our lab, Bich L. N. Than, explored the influence of CFTR dysregulation on 
intestinal cancer by using ApcMin mice with an intestinal-specific knockout (KO) of 
Cftr.  An ApcMin mouse has a point mutation in the homolog of the APC tumor 
suppressor gene (Moser et al., 1993). Than et al. (2016) found more tumors developed 
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in the small intestines and colons in Cftr mutant ApcMin mice than in Cftr wild-type 
ApcMin mice. In addition, they found that the loss of Cftr induced intestinal tumors in 
>60% of one year old Apc+/+ mice.  
Than et al. (2016) performed RNA Seq analysis of tumors from Cftr mutant 
Apc+/+ mice. RNA Seq is used for transcriptome profiling. It converts mRNA to cDNA 
fragments, performs short-read sequencing to these cDNA fragments, aligns these 
sequences with the reference genome or transcriptome, and allows quantification of the 
relative expression of genes in the sample (Parker et al., 2017; Wang, Gerstein & 
Snyder, 2009). The mRNA from tumors from Cftr mutant Apc+/+ mice was compared 
with mRNA from tumors from Cftr mutant ApcMin mice and Cftr wild-type ApcMin 
mice, and with mRNA from normal tissues from Cftr mutant Apc+/+ mice and Cftr 
wild-type Apc+/+ mice. RNA Seq identified dysgulation of several sets of genes 
including altered target genes of the Wnt β-catenin signaling and altered genes relating 
to the intestinal stem cell compartment (ISC) in tumors from Cftr mutant Apc+/+ mice 
compared to normal tissues from Cftr mutant Apc+/+ mice (Than et al., 2016). Gene set 
enrichment analysis (GSEA) was performed to evaluate the enrichment or depletion of 
gene sets in the Cftr depletion samples compared to the no depletion samples. GSEA is 
a computational method used to identify gene sets that are significantly altered in a 
given dataset (in a biological state) (Broad Institute, 2018). GSEA found an overlap in 
tumors from Cftr mutant Apc+/+ mice for ISC genes enriched in tumors from Cftr wild-
type ApcMin mice (Than et al., 2016). Microarray experiments were conducted to 
simultaneously compare the different gene expression levels of a large set of genes 
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between the Cftr depletion samples and the no depletion samples. Microarray 
experiments require the conversion of mRNA to cDNA fragments which undergo 
attachment to fluorescent markers and reaction with DNA probes, allowing for 
identification of target DNA via fluorescence (Govindarajan, Duraiyan, Kaliyappan & 
Palanisamy, 2012). Microarray analysis identified dysregulation of genes involved in 
the ion channel, immune responses, and cell fate decisions in normal tissues from Cftr 
mutant Apc+/+ mice (Than et al., 2016). Ingenuity Pathway Analysis (IPA) on 
microarray data was performed to identify pathways relating to or reacting with 
dysregulated gene expression (Jiménez-Marín, Collado-Romero, Ramirez-Boo, Arce & 
Garrido, 2009) following Cftr depletion. Applying this web-based software allowed for 
the identification of pathways that are altered in normal tissues from Cftr mutant Apc+/+ 
mice and further changed in tumors from Cftr mutant Apc+/+ mice. The analysis found 
an overlap for genes involved in lipid metabolism and immune responses (Than et al., 
2016).  
After that, Than et al. (2016) studied the correlation between CFTR expression 
and disease-free survival in CRC patients. The early stage human CRC patients were 
stratified by tumor CFTR gene expression, and risk of relapse in each group was 
determined. The data showed that in the microsatellite stable (MSS) subset, the three-
year relapse free survival in the CFTR high-expressing human CRC patients was 85%, 
while the three-year relapse free survival in the CFTR low-expressing human CRC 
patients was 56%, suggesting that CFTR deficiency was significantly correlated with 
lower disease-free survival (Than et al., 2016). The MSS is a subset of CRC, and MSS 
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tumors occur in 80-85% of CRC patients and do not respond to immunotherapies due 
to an already deficient immune response (Zhao, May, Lou & Subramanian, 2018).  
The Focus of this Project 
CFTR is a tumor suppressor for CRC (Than et al., 2016), but the mechanism by 
which CFTR prevents colorectal cancer is unknown. Our lab is trying to determine that 
mechanism and provide knowledge that can lead to new therapies for colorectal cancer. 
This project is focused on the unfolded protein response (UPR). This is because GSEA 
pathway analysis showed that CFTR-deficient normal and tumor tissues from mice and 
humans were enriched in genes involved in the UPR signaling pathway.  
Background on Unfolded Protein Response 
The main tasks of the endoplasmic reticulum (ER) include maintaining 
intracellular Ca2+ homeostasis and protein folding and transport (Corazzari, Gagliardi, 
Fimia & Piacentini, 2017). Altered ER homeostasis leads to the accumulation of 
unfolded or misfolded proteins, a condition called ER stress (Kaufman & Wang, 2016). 
The UPR is initiated in response to ER stress. Through activating a series of signaling 
pathways, UPR can increase the production of chaperones, reduce the synthesis of 
unfolded proteins, and increase the degradation of unfolded proteins (Kaufman & 
Wang, 2016). However, if the ER stress exceeds the functional capacity of the ER, the 
cell will enter apoptosis, or programmed cell death (Kaufman & Wang, 2016).  
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Figure 3. Adaptive and maladaptive UPR signaling pathways (Kaufman & Wang, 
2016). 
UPR activation can be adaptive and maladaptive in eukaryotic cells (Figure 3; 
Kaufman & Wang, 2016). When unfolded proteins bind to heat shock protein A 
member 5 (HSPA5), which is also called GRP78 or BIP, three molecules are released. 
These molecules are activating transcription factor 6 alpha (ATF6α), inositol-requiring 
protein 1 alpha (IRE1α), and protein kinase PKR-like ER kinase (PERK), and activate 
certain signaling pathways (Ni & Lee, 2007). The activation of IRE1α can lead to the 
alternative splicing of transcription factor X-box binding protein 1 (XBP1) transcripts 
(Lerner et al., 2012; Yoshida et al., 2001). The cleavage of ATF6α produces a 
transcriptionally active fragment (Lee et al., 2002). As a result, transcriptional response 
regulates the expression of genes involved in ER protein folding, increasing the 
capacity of the ER (Kaufman & Wang, 2016). Sensing ER stress activates the kinase 
function of PERK, phosphorylating the elongation initiation factor 2α (eIF2α) 
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(Kaufman & Wang, 2014). The phosphorylation of eIF2α promotes a pro-adaptive 
signal by suppressing global protein synthesis and selectively increasing activating 
transcription factor 4 (ATF4) transcripts that direct synthesis and transport of amino 
acids and temporary translation attenuation (Kaufman & Wang, 2014). As adaptive 
UPR, these three signaling pathways increase the capacity of the ER and contribute to 
cell survival.   
In contrast, maladaptive UPR ensues when hyperactivated irremediable ER stress 
exceeds the adaptive UPR capacity (Kaufman & Wang, 2016). Prolonged and severe 
ER stress can activate the PERK signaling pathway over time. EIF2α phosphorylation 
halts global translation including the synthesis of anti-apoptotic Bcl-2 proteins; ATF4 
directs transcription of the CCAAT/enhancer binding homologous protein (CHOP) 
gene, promoting programmed cell death (Hetz, 2012). IRE1α hyperactivation increases 
the thioredoxin-interacting protein (TXNIP) level by destabilizing its negative 
regulator, miR-17 (Lerner et al., 2012). The TXNIP gene encodes pro-oxidant protein 
which induces inflammation and cell death, and has been reported to contribute to the 
switch from adaptive to maladaptive UPR (Oslowski et al., 2012; Lerner et al., 2014). 
IRE1α activation recruits TNF-receptor-associated factor 2 (TRAF2) and Iκ kinase, 
contributing to the phosphorylation of c-Jun N-terminal kinase (JNK) (Urano et al., 
2000) and NF-κB (Hu, Han, Couvillon, Kaufman & Exton, 2006), respectively. As a 
result, the maladaptive UPR can be activated, which can lead to apoptosis. In addition, 
the ER stress-mediated leakage of calcium into the cytoplasm might result in the 
activation of death effectors, activating the apoptotic pathway (Rozpedek et al., 2016). 
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UPR in the Human Intestinal Secretory Cells 
At the mucosal interface with the microbial milieu, intestinal epithelial cells are 
stimulated to secrete a large amount of proteins (Kaser, Flak, Tomczak & Blumberg, 
2011). The excessive accumulation of unfolded proteins in the ER induces ER stress in 
the secretory cells (Kaser, Flak, Tomczak & Blumberg, 2011). The most important 
secretory cells in the intestine are Paneth cells and goblet cells (Kaser, Flak, Tomczak 
& Blumberg, 2011). Paneth cells have two delivery functions: they deliver signals on 
which the proliferation of stem cells relies, and they transport antimicrobial peptides 
into the lumen (Kaser, Flak, Tomczak & Blumberg, 2011). The goblet cells are 
responsible for the production and secretion of gel-forming mucins, which are used to 
protect mucosal membranes (Kaser, Flak, Tomczak & Blumberg, 2011). Highly 
secretory cells are vulnerable to ER stress, and these cells depend on a proper UPR for 
their secretory activities and homeostasis (Kaser & Blumberg, 2009). Genetic 
alterations including the impaired expression of genes involved in the adaptive ER 
function can damage the function of the UPR or cause the accumulation of unfolded 
proteins in the ER (Kaser et al., 2008). The unsolved and accumulated ER stress might 
exceed the functional capacity of the adaptive UPR. This disruption can lead to 
apoptosis, loss of Paneth and goblet cells, loss of mucosal barrier function, and 
inflammation (Kaser et al., 2008).  
UPR in the Intestinal Stem Cells 
Because cancer stem cells develop from oncogenic mutations in intestinal stem 
cells, CRC research is focused on the impact of the ER stress-induced UPR on the cell 
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fate of intestinal stem cells. Stem cells cycle and generate transit-amplifying cells 
capable of cycling and differentiating toward all lineages in the intestinal epithelium 
(Clevers, 2013). The unfolded protein response is activated and required when 
intestinal stem cells normally differentiate (Heijmans et al., 2013). Cell differentiation 
demands a variety of specialized proteins, which needs ER to process the accumulated 
unfolded proteins (Heijmans et al., 2013). ER stress-induced UPR makes intestinal 
stem cells lose their self-renewal capacity and differentiate (Heijmans et al., 2013). To 
maintain stemness capacity, intestinal stem cells need to reduce high levels of UPR 
activation. Otherwise, intestinal stem cells will be removed by differentiation.  
UPR in Cancer Cells 
Increased unfolded protein synthesis in cancer cells often creates increased ER 
stress and UPR activation (Dejeans, Barroso, Fernandez-Zapico, Samali, Chevet, 
2015). Mutations in oncogenes or tumor suppressors lead to the accumulation of 
unfolded proteins, activating UPR (Kaufman & Wang, 2014). Cancer cells proliferate 
and metastasize quickly and thus face a hostile environment with limited oxygen and 
nutrients, which disrupts ER homeostasis, induces ER stress and activates UPR 
(Kaufman & Wang, 2014; Ma & Hendershot, 2004). Tumors that survive the 
environmental stress possess high UPR activation (Chevet, Hetz & Samali, 2015). 
High UPR activity is believed to give cancer cells a survival advantage (Chevet, 
Hetz & Samali, 2015). According to the hallmarks of cancer, cancer cells can activate 
pathways to support the growth and survival of tumor cells (Hanahan & Weinberg, 
2011). Higher levels of UPR lead to the death of normal cells, but some cancer cells 
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protect themselves from and adapt to ER stress (Chevet, Hetz & Samali, 2015). The 
activated UPR can increase protein folding and the secretion of cytokines, angiogenesis 
factors, and extracellular matrix components, supporting the growth and survival of 
cancer cells (Corazzari, Gagliardi, Fimia & Piacentini, 2017). 
The Goal of This Project  
We hypothesize that the loss of CFTR increases protection from ER stress and that 
this protection supports the survival of CRC cells. To conceptualize a mechanism by 
which CFTR deficiency leads to CRC, a working model is proposed that UPR 
activation is enhanced in CFTR KO cells, and this activation contributes to CRC cell 
survival under ER stress. To test the hypothesis and evaluate the working model, a pair 
of CFTR knockout (KO) and wildtype (WT) Caco2 cell lines were used to test the 
correlation between UPR and cancer-supporting effects of CFTR-deficiency. These cell 
lines were created by CRISPR-Cas9 engineering by our collaborator Dr. Mitchell 
Drumm at Case Western Reserve University. Caco2 is a colon adenocarcinoma cell 
line commonly used as a model of the intestinal absorptive and defensive mucosa 
monolayer, and it has abundant CFTR expression (Sood et al., 1992; Borchardt, 2011). 
The goal of this project is to evaluate the working model by analyzing gene expression 
and utilizing cell viability assays.  
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Figure 4. Working model. 
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Results 
We hypothesized that loss of CFTR increases UPR activation, and that this 
activation supports the survival of CRC cells under ER stress. To investigate the 
mechanism underlying CRC suppression by CFTR, a pair of CFTR knockout (KO) and 
wildtype (WT) Caco2 cell lines were utilized to test the correlation between UPR and 
the cancer-supporting effects of CFTR-deficiency. We hypothesized that the loss of 
CFTR might increase UPR activation. To evaluate the UPR activities in CFTR KO 
cells, RT-qPCR analysis was performed to examine the gene expression changes 
involved in the UPR signaling pathway.  
RT-qPCR for CFTR Validates CFTR KO Cells 
Initially, it was necessary to confirm that CFTR expression is relatively low in 
CFTR KO cells. CFTR KO and WT Caco2 cell lines were created by CRISPR-Cas9 
engineering by our collaborator Dr. Mitchell Drumm at Case Western Reserve 
University. A frameshift mutation occurs in the exon 11 in the coding region of CFTR 
on chromosome 7 in CFTR KO cells. RT-qPCR was conducted to evaluate the 
expression of CFTR in the CFTR KO and WT Caco2 cell lines. One million (106) 
CFTR WT and CFTR KO Caco2 cells were plated into 60 mm tissue culture dishes and 
cultured overnight, and total RNA was extracted from the CFTR WT and CFTR KO 
Caco2 cells. The CFTR mRNA expression levels were determined by RT-qPCR. To 
minimize technical variations, the expression of CFTR was normalized to the 
expression of 18S. The results showed that the expression of CFTR in CFTR KO cells 
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was lower than in CFTR WT cells (Figure 5). RT-qPCR for CFTR verifies CFTR KO 
cells. 
 
Figure 5. Expression of CFTR in CFTR WT and CFTR KO Caco2 cell lines. CFTR 
mRNA expression in CFTR WT and CFTR KO cells was measured by RT-qPCR. The 
expression of CFTR was normalized to the expression of 18S. 
 
The Expression of Genes Associated with UPR in CFTR WT and CFTR KO Caco2 
Cell Lines  
We hypothesized that the loss of CFTR might increase the UPR activation. To 
assess the UPR activities in CFTR KO and WT cells, RT-qPCR analysis was conducted 
to compare the gene expression changes involved in the UPR signaling pathway in 
CFTR WT and CFTR KO Caco2 cell lines. To compare the mRNA expression of genes 
relating to the UPR signaling pathway in CFTR WT and CFTR KO cells, one million 
(106) CFTR WT and CFTR KO Caco2 cells were plated into 60 mm tissue culture 
dishes and cultured overnight, and total RNA was extracted from CFTR WT and CFTR 
KO Caco2 cells. The mRNA expression levels were determined by RT-qPCR. To 
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evaluate the UPR activities in CFTR KO cells under ER stress, RT-qPCR analysis was 
performed to compare the gene expression changes involved in the UPR signaling 
pathway in CFTR WT and CFTR KO Caco2 cell lines treated with Thapsigargin (TG) 
to induce ER stress. To compare the mRNA expression of genes relating to the UPR 
signaling pathway in CFTR WT and CFTR KO cells treated with inducers to trigger ER 
stress, one million (106) CFTR WT and CFTR KO Caco2 cells were plated into 60 mm 
tissue culture dishes, cultured overnight, treated with 0.2 µM TG for 2.5 hours, and 
total RNA was extracted from DMSO controls and treated CFTR WT and CFTR KO 
Caco2 cells. TG inhibits sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) 
and breaks down ER Ca2+ gradient (Oslowski & Urano, 2011). The lower calcium 
levels in the ER disrupt dependent chaperone activities and induce ER stress (Oslowski 
& Urano, 2011). TG can be dissolved in DMSO, and the low concentration of DMSO 
was added to cells to serve as a no treatment control. The mRNA expression levels 
were determined by RT-qPCR. To minimize technical variations, the expression of 
each gene of interest was normalized to the expression of 18S. Each bar represents the 
mean, and error bars represent the standard deviation of 3 biological replicates, unless 
otherwise stated. A paired two-tailed t-test was used to determine the statistical 
significance of the entirety of the RT-qPCR data and MTT data in this thesis. All 
statistical tests used a significance value of α = 0.05. Comparisons of p ≤ 0.05 are 
marked by an asterisk *.  
The HSPA5 gene encodes the chaperone protein GRP78 that serves as the 
gatekeeper of UPR (Zhu & Lee, 2015). Sensing of ER stress dissociates GRP78 from 
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ATF6α, IRE1α and PERK, initiating all three UPR sub-pathways (Kaufman & Wang, 
2016). The HSPA5 expression levels in CFTR WT and CFTR KO cells were analyzed. 
The basal levels of the HSPA5 in CFTR WT and CFTR KO cells were not different 
(Figure 6a). The expression of the HSPA5 was analyzed in CFTR WT and CFTR KO 
cells treated with TG as well as in untreated controls (Figure 6). To determine the effect 
of ER stress on gene expression in each cell line, the ratio of TG treated over untreated 
gene expression levels was analyzed (Figure 6b). The expression levels of the HSPA5 
gene in both CFTR WT and CFTR KO cells increased after TG treatment. The HSPA5 
expression levels were increased to 2.2 and 3.8-fold (Figure 6b), respectively, in CFTR 
WT and CFTR KO cells. The effect of the TG treatment on HSPA5 expression in CFTR 
KO cells was more than the effect of the TG treatment on HSPA5 expression in CFTR 
WT cells. The difference between the expression levels in WT and KO cells after 
treatment is not statistically significant at p ≤ 0.05. A trend was suggested by these data 
that CFTR deficiency may raise the effect of TG-induced ER stress on the expression 
of the UPR gatekeeper HSPA5.  
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Figure 6. Expression of HSPA5 in CFTR WT and CFTR KO Caco2 cell lines. HSPA5 
mRNA expression (a) (b) was measured by RT-qPCR. The expression of HSPA5 was 
normalized to the expression of 18S. (a) The Y-axis refers to the ratio of CFTR KO 
cells over CFTR WT cells gene basal expression levels. (b) The Y-axis refers to the 
ratio of TG treated over untreated gene expression levels.  
 
The PERK signaling target ATF4 transcripts regulate the synthesis and transport 
of amino acids and temporary translation attenuation (Kaufman & Wang, 2014). ATF4 
expression levels in CFTR WT and CFTR KO cells were analyzed. The basal levels of 
ATF4 in CFTR WT and CFTR KO cells were not different (Figure 7a). The expression 
of ATF4 was analyzed in CFTR WT and CFTR KO cells treated with TG as well as in 
untreated controls. To determine the effect of ER stress on gene expression in each cell 
line, the ratio of TG treated over untreated gene expression levels was analyzed (Figure 
7b). The expression levels of the ATF4 gene in both CFTR WT and CFTR KO cells 
increased after TG treatment. ATF4 expression levels increased to the same extent in 
both CFTR WT and CFTR KO cells (Figure 7b). These data indicate that the loss of 
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CFTR might not influence the effect of TG-induced ER stress on the expression of 
PERK signaling target gene ATF4.  
 
Figure 7. Expression of ATF4 in CFTR WT and CFTR KO Caco2 cell lines. ATF4 
mRNA expression (a) (b) was measured by RT-qPCR. The expression of ATF4 was 
normalized to the expression of 18S. (a) The Y-axis refers to the ratio of CFTR KO 
cells over CFTR WT cells gene basal expression levels. (b) The Y-axis refers to the 
ratio of TG treated over untreated gene expression levels.  
 
Wang and Kaufman (2016) state that the three UPR sub-pathways are not 
simultaneously activated by ER stress, thus it is of interest to evaluate the activities of 
other UPR signaling branches. To evaluate IRE1α activities in CFTR KO cells, RT-
qPCR analysis was performed to assess gene expression changes involved in the IRE1α 
signaling pathway. To compare the mRNA expression of genes relating to the IRE1α 
signaling pathway in CFTR WT and CFTR KO cells, one million (106) Caco2 cells 
were plated into 60 mm tissue culture dishes, cultured overnight, and total RNA was 
extracted from CFTR WT and CFTR KO Caco2 cell lines without artificially sustained 
ER stress. The mRNA expression levels were determined by RT-qPCR. 
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The expression of total XBP1 was analyzed in CFTR WT and CFTR KO Caco2 
cell lines (Figure 8) by Amanda Palme. Under remediable ER stress, IRE1α activation 
restricts its carboxy-terminal ribonuclease activity toward the mRNA encoding XBP-1, 
leading to the alternative splicing of XBP1 unspliced mRNA (Lerner et al., 2012; 
Yoshida et al., 2001). The XBP1 spliced mRNA is translated to an active transcription 
factor that triggers the expression of genes involved in adaptive functions such as 
protein folding, protein quality control, phospholipid synthesis, and ER-associated 
degradation of misfolded proteins (Hetz, Martinon, Rodriguez & Glimcher, 2011). In 
this experiment, the expression of XBP1 in CFTR WT cells was higher than the 
expression of XBP1 in CFTR KO cells (Figure 8). The ratio of XBP1 levels in CFTR 
KO cells over CFTR WT cells is 0.58. The difference between the expression levels in 
WT and KO cells is not statistically significant at p ≤ 0.05. A trend was suggested by 
these data that the loss of CFTR might decrease total XBP1 expression.   
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Figure 8. Expression of XBP1 in CFTR WT and CFTR KO Caco2 cell lines. XBP1 
mRNA expression was measured by RT-qPCR. The expression of XBP1 was 
normalized to the expression of 18S. The Y-axis refers to the ratio of CFTR KO cells 
over CFTR WT cells gene expression levels.  
 
The expression of thioredoxin-interacting protein (TXNIP) was analyzed in CFTR 
WT and CFTR KO Caco2 cell lines (Figure 9) by Amanda Palme. Under excessive ER 
stress, IRE1α activation enhances TXNIP levels by destabilizing miR-17 (Lerner et al., 
2012). The TXNIP gene encodes pro-oxidant proteins leading to inflammation and cell 
death and has been reported to contribute to the switch from adaptive to maladaptive 
UPR (Oslowski et al., 2012; Lerner et al., 2014). In this experiment, CFTR WT cells 
had an increased expression of TXNIP than CFTR KO cells (Figure 9). The ratio of 
TNXIP levels in CFTR KO cells over CFTR WT cells is 0.32. The standard deviation 
of 2 biological replicates is 0.018. The difference between the expression levels in WT 
and KO cells is statistically significant at p ≤ 0.05 (p=0.012). These data suggest that 
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the loss of CFTR results in a decrease in the expression of TXNIP. 
 
Figure 9. Expression of TXNIP in CFTR WT and CFTR KO Caco2 cell lines. TXNIP 
mRNA expression was measured by RT-qPCR. The expression of TXNIP was 
normalized to the expression of 18S. The Y-axis refers to the ratio of CFTR KO cells 
over CFTR WT cells gene expression levels. The standard deviation for two biological 
replicates is shown by the error bars. Statistical significance was determined by a 
paired two-tailed t-test. * = p < 0.05.  
  
To determine if the loss of CFTR enhances UPR activation, we examined the 
effect of CFTR deficiency on expression of genes involved in the UPR activities. The 
increased effect of TG treatment on HSPA5 expression in CFTR KO suggests a trend 
that the loss of CFTR might enhance the effect of ER stress on the expression of the 
UPR gatekeeper HSPA5, the common regulator for initiating three UPR sub-pathways. 
The increase to the same extent in ATF4 expression in both CFTR WT and CFTR KO 
cells reflects that the loss of CFTR might not enhance the activation of PERK 
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signaling. The decreased levels of total XBP1 mRNA in CFTR KO cells reflect that 
CFTR deficiency might not activate the IRE1α signaling pathway. TXNIP, which is 
part of an apoptotic pathway, is down-regulated in CFTR KO cells. This down 
regulation might provide protection from apoptosis. Together, these studies suggest that 
UPR activation might be up-regulated in CFTR KO cells, but the specific pathway 
might not be the one addressed in this study. In addition, the down regulation of TXNIP 
might offer protection for cancer cells from apoptosis. Except the TXNIP, these data 
from these three genes did not show a statistically significant difference. More studies 
are required to evaluate UPR activities in CFTR WT and CFTR KO cells and thereby 
support or refute our hypotheses.  
Cell Viability of CFTR WT and CFTR KO Caco2 Cell Lines  
Although many cancer cells require an enhanced UPR, excessive prolonged 
activation triggers a switch to an apoptotic pathway (Wang & Kaufman, 2016; 
Niederreiter, L. et al., 2013). To detect if the loss of CFTR protects the survival of CRC 
cells in the presence of hyperactivated irremediable ER stress, cell viability of CFTR 
KO and WT cells under ER stress was compared. The initial step was to compare the 
cell viability of CFTR WT and CFTR KO Caco2 cell lines before TG treatment by 
using the MTT assay. Twenty-five hundred (2,500) Caco2 cells per well, 5,000 Caco2 
cells per well and 10,000 Caco2 cells per well with 6 technical replicates were plated 
into 96 well plates and cultured from 18 hours to 90 hours in 1 biological replicate. Cell 
viability was determined by the MTT assay. The cell viability of the CFTR WT Caco2 
cells before TG treatment was higher than that of the CFTR KO Caco2 cells over the 
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duration of plating (Figure 10). These data reflect the variations between cell growth of 
the two cell lines. 
 
Figure 10. MTT cell viability assay in CFTR WT and CFTR KO Caco2 cell lines. The 
cell viability of CFTR WT and CFTR KO Caco2 cell lines was measured by the MTT 
assay. The Y axis refers to absorbance which reflects cell viability. 
 
To evaluate if the loss of CFTR protects the survival of CRC cells in the presence 
of excessive ER stress, the MTT assay was performed to compare cell viability of 
CFTR KO and WT cells treated with TG to induce ER stress. A dose gradient was 
utilized to select the concentration of TG used for treatment. Ten thousand (10,000) 
Caco2 cells per well with 6 technical replicates were plated into 96-well plates, 
cultured overnight and treated with TG. Cells were treated with different doses of TG 
(0.2µM, 0.4µM, 0.8µM) from 2 hours to 72 hours in 1 biological replicate. Cell 
viability was determined by the MTT assay. The ratio of treated over untreated viability 
of both CFTR KO and WT cells decreased over the duration of TG treatment from 2 
hours to 72 hours (Figure 11). We chose 0.2 µM TG to treat Caco2 cells because it is 
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the lowest dose that affects the cell viability of CFTR KO and WT Caco2 cell lines 
within 72 hours in this experiment (Figure 11).  
 
Figure 11. MTT cell viability assay in CFTR WT and CFTR KO Caco2 cell lines after 
TG treatment. The cell viability of CFTR WT and CFTR KO Caco2 cell lines after 
treatment with different doses of TG, as indicated, was measured by the MTT assay 
from 2 hours to 72 hours. The Y-axis refers to the ratio of treated over untreated 
viability of Caco2 cell lines.   
 
To evaluate if the CFTR deficiency promotes the survival of CRC under 
hyperactivated irremediable ER stress, the MTT assay was conducted to compare the 
cell viability of CFTR KO and WT Caco2 cell lines treated with TG to induce ER 
stress. Five thousand (5,000) Caco2 cells per well with 6 technical replicates were 
plated into 96 well plates, cultured overnight and treated with TG. Cells were treated 
with 0.2µM TG from 3 hours to 72 hours. Cell viability was determined by the MTT 
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assay. The previous experiment suggested that the cell viability of CFTR WT and 
CFTR KO cells differ between plating. For the analysis in this experiment, MTT values 
at each point were normalized to 3 hour untreated controls for CFTR WT and CFTR 
KO cells to control the variations in plating. To determine the effect of ER stress on 
each cell line, the ratio of treated over untreated viability at each point was analyzed. 
The TG treatment gave rise to decreased cell viability in both CFTR WT and CFTR KO 
cells over time. The cell viability decreased to about 26% and 43%, respectively, in 
CFTR WT and CFTR KO cells at 72 hours. The ratio of treated over untreated viability 
was higher in CFTR KO cells than that in WT cells (Figure 12). The difference 
between the ratios in WT and KO cells is statistically significant at p ≤ 0.05 (p=0.049, 
Figure 12). These data indicate that CFTR deficiency causes TG-induced ER stress to 
have less of an effect on cell viability.  
  
 
 
 
 
 
 
 
 
 
   30 
 
  
Figure 12. MTT cell viability assay in CFTR WT and CFTR KO Caco2 cell lines after 
TG treatment. The cell viability of CFTR WT and CFTR KO Caco2 cell lines after 
treatment with TG was measured by the MTT assay from 3 hours to 72 hours. The Y-
axis refers to the ratio of treated over untreated viability of Caco2 cell lines. Statistical 
significance of differences in cell viability at each time point was determined by a 
paired two-tailed t-test. The difference at 72 hours was found to be statistically 
significant.  
* = p ≤ 0.05.  
 
To evaluate if CFTR deficiency supports the survival of CRC cells under 
excessive ER stress, the MTT assay was conducted to compare the cell viability of 
CFTR KO and WT Caco2 cell lines treated with another inducer, Tunicamycin (TM), 
to trigger ER stress. TM suppresses UDP-N-acetylglucosamine-dolichol phosphate N-
acetylglucosamine-1-phosphate transferase (GPT) and thus halts the initiation of 
glycoprotein biosynthesis in the ER (Oslowski & Urano, 2011). The unglycosylated 
proteins cannot leave the ER, so there is an accumulation causing ER stress (Oslowski 
& Urano, 2011). Twenty thousand (20,000) Caco2 cells per well with 6 technical 
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replicates were plated into 96-well plates, cultured overnight and treated with TM. 
Cells were treated with different doses of TM (2.5 µg/ml, 5 µg/ml, 10 µg/ml) from 2 
hours to 72 hours in 1 biological replicate. Cell viability was determined by the MTT 
assay. For analysis, MTT values at each point were normalized to 0 hour untreated 
controls for CFTR WT cells and CFTR KO cells to control the variations in plating. To 
determine the effect of ER stress on each cell line, the ratio of treated over untreated 
viability at each point was analyzed. The TM treatment resulted in dose- and time- 
dependent decreases in cell viability in both CFTR WT and CFTR KO cells (Figure 
13). The ratio of treated over untreated viability was higher in CFTR KO cells at 72 
hours than in WT cells (Figure 13). The difference between the ratios in WT and KO 
cells is not statistically significant at p ≤ 0.05. A trend has been suggested by these data 
that CFTR deficiency causes TM-induced ER stress to have less of an effect on cell 
viability. 
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Figure 13. MTT cell viability assay in CFTR WT and CFTR KO Caco2 cell lines after 
TM treatment. The cell viability of CFTR WT and CFTR KO Caco2 cell lines after 
treatment with different doses of TM, as indicated, was measured by the MTT assay 
from 2 hours to 72 hours. The Y-axis refers to the ratio of treated over untreated 
viability of Caco2 cell lines. 
 
To evaluate the relationship between CFTR deficiency and protection for CRC 
cells from ER stress, we compared the cell viability of CFTR KO and WT cells treated 
with two different inducers, TG and TM, to induce ER stress. The higher ratio of 
treated over untreated viability in CFTR KO cells suggests that the loss of CFTR causes 
ER stress to have less effect on cell viability. These data indicate that the loss of CFTR 
might protect the survival of CRC cells under excessive ER stress. 
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Gene Expression Analysis of the NF-κB Signaling Pathway in CFTR WT and 
CFTR KO Caco2 Cell Lines 
Grootjans et al. (2016) demonstrated that ER stress-induced UPR activates the 
NF-κB signaling pathway. Recent research shows that CFTR deficiency activates the 
NF-κB signaling pathway (Crites et al., 2015). We hypothesized that CFTR deficiency 
positively affects the NF-κB signaling pathway in the presence of UPR. To assess the 
innate NF-κB activities in CFTR KO and WT cells, RT-qPCR analysis was performed 
to compare the gene expression changes involved in the NF-κB signaling pathway in 
CFTR WT and CFTR KO Caco2 cell lines. To compare the mRNA expression of genes 
relating to the NF-κB signaling pathway in CFTR WT and CFTR KO, one million (106) 
CFTR WT and CFTR KO Caco2 cells were plated into 60 mm tissue culture dishes and 
cultured overnight, and total RNA was extracted from CFTR WT and CFTR KO Caco2 
cells. The mRNA expression levels were determined by RT-qPCR. To evaluate the NF-
κB activity in CFTR KO cells in response to UPR, RT-qPCR analysis was conducted to 
compare the gene expression changes involved in NF-κB signaling pathway in CFTR 
WT and CFTR KO Caco2 cell lines treated with TG to trigger ER stress. To evaluate 
the mRNA expression of genes relating to the NF-κB signal in CFTR KO cells, one 
million (106) CFTR WT and CFTR KO Caco2 cells were plated into 60 mm tissue 
culture dishes, cultured overnight, treated with 0.2 µM TG for 2.5 hours, and total RNA 
was extracted from DMSO controls and treated CFTR WT and CFTR KO Caco2 cells. 
The mRNA expression levels were determined by RT-qPCR. To minimize technical 
variations, the expression of each gene of interest was normalized to the expression of 
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18S. 
Interleukin-8 (IL8, CXCL8) is a cytokine that plays an important role in the 
recruitment of inflammatory cells and growth of colon carcinoma cell lines 
(Matsushima & Oppenheim, 1989; Brew et al., 1999). The IL8 expression levels in 
CFTR WT and CFTR KO cells were analyzed. In this experiment, the CFTR KO cells 
had a higher expression of IL8 than CFTR WT cells (Figure 14a). The ratio of IL8 basal 
levels in CFTR KO cells over CFTR WT cells is 1.6. The data suggest that CFTR 
deficiency might enhance IL8 expression. The expression of IL8 was analyzed in CFTR 
WT and CFTR KO Caco2 cell lines treated with TG as well as in untreated controls. To 
determine the effect of ER stress on gene expression in each cell line, the ratio of TG 
treated over untreated gene expression levels was analyzed (Figure 14b). The 
expression levels of the IL8 gene in both CFTR WT and KO cells increased after TG 
treatment. The IL8 expression levels were increased 44.7 and 15.5-fold, respectively, in 
CFTR WT and CFTR KO cells (Figure 14b). The effect of the TG treatment on IL8 
expression in CFTR WT cells was more than the effect of the TG treatment on IL8 
expression in CFTR KO cells (Figure 14b). The difference between the expression 
levels in WT and KO cells after treatment is not statistically significant at p ≤ 0.05. A 
trend was suggested by these data that the loss of CFTR causes TG to have less of an 
effect on IL8 expression. 
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Figure 14. Expression of IL8 in CFTR WT and CFTR KO Caco2 cell lines. IL8 mRNA 
expression (a) (b) was measured by RT-qPCR. The expression of IL8 was normalized 
to the expression of 18S. (a) The Y-axis refers to the ratio of CFTR KO cells over 
CFTR WT cells gene basal expression levels. (b) The Y-axis refers to the ratio of TG 
treated over untreated gene expression levels.  
 
Tumor Necrosis Factor (TNF) is a cytokine involved in the regulation of 
inflammation, proliferation, and apoptosis (Gaur & Aggarwal, 2003). TNF is not only 
induced by NF-κB but the binding of TNF to tumor necrosis factor receptor (TNFR) 
also indirectly activates the NF-κB signaling pathway (Gaur & Aggarwal, 2003). The 
TNF expression levels in CFTR WT and CFTR KO cells were analyzed. In the 
experiment, there was no notable difference between the basal expression levels of 
TNF in CFTR WT and CFTR KO cells (Figure 15a). The TNF expression levels were 
analyzed in CFTR WT and CFTR KO Caco2 cell lines treated with TG as well as in 
untreated controls. TNF mRNA expression in both CFTR WT and KO cells increased 
after TG treatment. The TNF expression levels increased 2.3 and 1.5-fold, respectively, 
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in CFTR WT and CFTR KO cells (Figure 15b). The effect of the TG treatment on TNF 
expression in CFTR WT was more than the effect of the TG treatment on TNF 
expression in CFTR KO cells (Figure 15b). The difference between the expression 
levels in WT and KO after treatment is not statistically significant at p ≤ 0.05. A trend 
was suggested by these data that the loss of CFTR causes TG to have less of an effect 
on TNF expression.  
 
Figure 15. Expression of TNF in CFTR WT and CFTR KO Caco2 cell lines. TNF 
mRNA expression (a) (b) was measured by RT-qPCR. The expression of TNF was 
normalized to the expression of 18S. (a) The Y-axis refers to the ratio of CFTR KO 
cells over CFTR WT cells gene basal expression levels. (b) The Y-axis refers to the 
ratio of TG treated over untreated gene expression levels.  
 
The IL8 and TNF gene expression data consistently indicate that CFTR deficiency 
cause TG to produce less of an effect on the expression of NF-κB signaling target 
genes IL8 and TNF. These data suggest that the loss of CFTR might cause TG-induced 
UPR to have less of an effect on NF-κB activation, but the difference is not statistically 
significant. More studies need to be conducted to confirm or refute this conclusion. 
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Discussion 
The purpose of this thesis was to detect the mechanism by which CFTR deficiency 
might lead to CRC. GSEA pathway analysis suggested that CFTR-deficient normal and 
tumor tissues from mice and humans had an enriched expression in genes involved in 
the UPR. Altered genes, environmental stress, and increased protein synthesis induce 
UPR activation in cancer cells (Kaufman & Wang, 2014; Ma & Hendershot, 2004; 
Dejeans, Barroso, Fernandez-Zapico, Samali, Chevet, 2015). UPR has two potentially 
opposing effects on cancer development. On the one hand, some cancer cells need a 
higher level of UPR to support their growth and survival (Corazzari, Gagliardi, Fimia 
& Piacentini, 2017); on the other hand, increased UPR causes loss of stemness which 
could inhibit cancer development (Heijmans et al., 2013). To identify the correlation 
between CFTR deficiency and UPR activation and its effect on CRC, a pair of CFTR 
KO and WT Caco2 cell lines were utilized to test the working model that UPR 
activation might be enhanced in CFTR KO cells, and that this activation might protect 
CRC cell survival under ER stress. We tested the working model by observing Caco2 
cell lines treated with inducers to trigger ER stress. The UPR activities were evaluated 
by observing mRNA expression changes of key genes. The protection from ER stress 
was evaluated by analyzing cell viability. These data support the hypothesis that the 
loss of CFTR increases protection from ER stress and that this protection supports the 
survival of CRC cells. However, the data alone does not sufficiently support my 
hypothesis.  
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RT-qPCR for CFTR Validates CFTR KO Cells 
The mechanism underlying CRC suppression by CFTR has not been discovered. 
To investigate the mechanism, a pair of CFTR KO and CFTR WT Caco2 cell lines 
created by CRISPR-Cas9 engineering were used. Initially, the expression of CFTR in 
CFTR KO and CFTR WT cells was compared. CFTR is estimated to show relatively 
low expression in CFTR KO cells. RT-qPCR analysis agrees with the estimation that 
the expression of CFTR in CFTR KO cells is lower than in CFTR WT cells (Figure 5). 
However, CFTR is still expressed in RT-qPCR analysis of CFTR KO cells. These data 
suggest that CFTR might not be totally knocked out in CFTR KO Caco2 cells, even 
though the expression is decreased. CRISPR-Cas9 was used to induce a frameshift 
mutation in the exon 11 in the coding region of CFTR on chromosome 7 in CFTR KO 
cells, thereby knocking out CFTR. Theoretically, the unstable mRNA was expected to 
be degraded, and no CFTR protein would be produced. The primer used amplifies the 
DNA sequence that partly covers the 5’untranslated region (5’UTR) and partly covers a 
region in exon 1 on chromosome 7. It is possible that the 5’UTR and a portion of the 
protein-coding region accounts for the small amount seen in the knockout clone.  
The question arises how CFTR KO cells induces UPR. We assume UPR might be 
activated through two different mechanisms. The first possibility is that CFTR mRNA 
with coding region might survive from degradation, as with delta 508 (Bartoszewski et 
al., 2008; Chung et al., 2016). In this case, the surviving partial mRNA might be 
translated into misfolded proteins, and the accumulation of the misfolded proteins 
might induce UPR. The second possible explanation is based on the biological function 
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of CFTR protein. CFTR is a chloride ion channel which regulates cytoplasmic chloride 
levels (De Lisle & Borowitz, 2013), and the uptake of Ca2+ into the ER lumen is 
important for maintaining the ER Ca2+ gradient (Pollock, Kargacin & Kargacin, 1998). 
Pollock et al. (1998) reported that chloride channel blockage suppresses Ca2+ uptake by 
Sarcoplasmic Reticulum. It is possible that the dysfunction of CFTR might impair the 
uptake of Ca2+, and disrupted Ca2+ homeostasis induces ER stress (Oslowski & Urano, 
2011). RT-qPCR can be used to detect what part is left in the mRNA of CFTR KO 
cells. Through designing primers amplifying the DNA sequence that covers each exon 
of CFTR coding region, we can tell which exon of CFTR gene is included or excluded 
in CFTR KO cells. If all exons are excluded, it may support the second possible 
explanation. Otherwise, the first possibility that misfolded proteins are transcribed from 
a portion of mRNA might account for the UPR activation in CFTR KO cells. Western 
blot could be used to identify if CFTR proteins are present. If CFTR proteins exist, 
these proteins might be misfolded proteins because exon 11 is depleted and the normal 
proteins might not be produced. If CFTR proteins are present, the first possibility might 
explain the UPR activation in CFTR KO Caco2 cell line. 
CFTR Deficiency in Caco2 Cell Lines Might Alter UPR Activation     
To detect the biological pathways affected by CFTR deficiency in CRC, gene 
expression data analyses from CFTR-deficient normal and tumor tissues from mice and 
humans were conducted through Gene Set Enrichment Analysis (GSEA). GSEA 
pathway analysis suggested that CFTR-deficient normal and tumor tissues from mice 
and humans were enriched in genes involved in the unfolded protein response. GSEA 
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offers informative suggestions, but these suggestions are not enough to draw 
conclusions, and analyzing gene expression in CFTR WT and CFTR KO Caco2 cell 
lines was necessary to help examine the UPR activities in CFTR KO cells. We 
evaluated mRNA expression changes of key genes relating to the UPR by performing 
RT-qPCR. The results showed no difference between the basal expression levels of 
HSPA5 in CFTR WT and CFTR KO. To determine the effect of TG treatment and 
induction of ER stress on gene expression in each cell line, the ratio of gene expression 
in treated cells over untreated cells was analyzed. The expression of HSPA5 increased 
after TG treatment in both CFTR WT and CFTR KO cells, which agreed with our 
expectation that TG-induced ER stress activates the UPR. The TG treatment had more 
of an effect on HSPA5 expression in CFTR KO cells than on HSPA5 expression in 
CFTR WT cells. This indicates that CFTR deficiency promotes the effect of TG-
induced ER stress on the expression of UPR gatekeeper HSPA5, the common regulator 
for initiating three UPR sub-pathways. This is consistent with the suggestion of GSEA 
that the loss of CFTR enhances UPR activation.  
No difference was found between the basal expression levels of ATF4 in CFTR 
WT and CFTR KO. The expression of ATF4 increased after treatment in both cell lines, 
which agreed with our expectation that TG-induced ER stress might activate UPR, 
especially the PERK signaling pathway. However, ATF4 expression increased to the 
same extent in both WT and KO cells, suggesting that the loss of CFTR might not 
influence the effect of TG-induced ER stress on the expression of the PERK signaling 
target gene ATF4. The RT-qPCR data of ATF4 expression did not support our 
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hypothesis that CFTR deficiency increases the expression of UPR target genes in 
response to TG induced UPR. The data reflect that the loss of CFTR might not enhance 
the activation of PERK signaling. 
The data of HSPA5 and ATF4 gene expression suggest that the loss of CFTR 
might increase UPR activities in response to ER stress but might not affect the 
influence of TG-induced ER stress on the expression of the PERK signaling target gene 
ATF4. Since we only tested mRNA expression levels of two genes, the conclusions we 
can draw from this analysis are limited. Protein expression levels need to be analyzed 
in order to draw more precise and accurate conclusions in the future. ATF4 is not the 
only target gene of the PERK-eIF2α signaling, so analyzing the expression of other 
PERK signaling target genes might help evaluate the activities of this pathway more 
comprehensively.  
In addition, Wang and Kaufman (2016) demonstrated that the three UPR sub-
pathways, ATF6α, IRE1α and PERK, are not simultaneously activated by ER stress. 
Since we did not see an effect of CFTR deficiency on the specific PERK-eIF2α-ATF4 
signaling, it is of interest to examine the activities of other UPR signaling branches. 
IRE1α plays an important role in cell fate. A study conducted by Li et al. (2017) 
suggests that knockdown of IRE1α suppresses tumorigenesis in colon cancer through 
decreasing β-catenin. The spliced XBP1 mRNA by IRE1α activation is important for 
triggering adaptive functions in UPR (Hetz, Martinon, Rodriguez & Glimcher, 2011). 
Many studies reported that under excessive ER stress, IRE1α activation enhances 
TXNIP levels by destabilizing miR-17 (Oslowski et al., 2012; Lerner et al., 2012). The 
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increased TXNIP levels promote the switch from adaptive to maladaptive UPR 
(Oslowski et al., 2012; Lerner et al., 2012) and initiates apoptotic pathways (Zhao et 
al., 2017; Lerner et al., 2012; Oslowski et al., 2012). To further investigate the UPR 
activities in CFTR KO cells, it is interesting to observe the expression of these two 
genes without artificially sustained ER stress. RT-qPCR was conducted to evaluate the 
expression of these two genes in CFTR KO and CFTR WT cells without TG treatment. 
A decrease in the expression of XBP1 in CFTR KO cells suggests that the loss of CFTR 
might decrease total XBP1 expression. The expression of spliced XBP1 is expected to 
be up-regulated in CFTR KO cells in order to increase protein folding and cell survival. 
However, the total expression of XBP1 was decreased in the CFTR KO cells in our 
experiment. This reflects that CFTR deficiency might not activate a specific IRE1α-
XBP1 signaling pathway. It is of interest to investigate the ratio of spliced XBP1 to 
unspliced XBP1. It is probable that the expression of spliced XBP1 increased in CFTR 
KO cells even though the total XBP1 expression decreased. The primer pair we used 
amplifies both unspliced and spliced sequences. More experiments need to be 
conducted to differentiate spliced XBP1 from unspliced XBP1 in the PCR product.  
The decreased expression of TXNIP in CFTR KO cells suggests that the loss of 
CFTR might decrease TXNIP expression levels. Many studies reported that TXNIP 
expression is induced through the IRE1α and PERK signaling pathways (Lerner et al., 
2012). PERK- eIF2α phosphorylation increases the translation of ATF5 that binds to 
the TXNIP promoter and increases TXNIP expression (Oslowski et al., 2012). Under 
hyperactivated irremediable ER stress IRE1α increases TXNIP mRNA stability by 
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triggering the decay of its regulator miR-17 (Lerner et al., 2012). Increased TXNIP 
levels promote apoptotic pathways (Zhao et al., 2017; Lerner et al., 2012; Oslowski et 
al., 2012). The down regulation of TXNIP in CFTR KO cells might provide protection 
from apoptosis. 
Considering the two specific IRE1α pathways, the data of XBP1 expression 
reflects that CFTR deficiency might not activate the specific IRE1α-XBP1 signaling 
pathway that is important for UPR adaptive functions and cell survival; the data of 
TXNIP expression suggest that the loss of CFTR might decrease the specific IRE1α- 
TXNIP pathway which initiates apoptotic pathways. The down regulation in TXNIP 
expression in CFTR KO cells might protect cancer cells from apoptosis. However, in 
these experiments, we have only tested the mRNA expression levels of these two genes 
without TG treatment which can induce excessive ER stress. We did not evaluate the 
expression of these two genes under hyperactivation of IRE1α. The conclusions we can 
draw from this analysis are limited. More studies need to be performed to compare the 
impact of CFTR deficiency on TXNIP expression under low ER stress and excessive 
ER stress. 
To summarize, the data from these four experiments suggest that UPR activation 
might be up-regulated in CFTR KO cells, but the specific pathway might not be the one 
addressed in this study. In addition, the down regulation of TXNIP might offer 
protection for cancer cells from apoptosis. Except the TXNIP, the data of HSPA5, ATF4 
and XBP1 genes did not show a statistically significant difference. The conclusions we 
can draw from these experiments are restricted. In addition to these four genes, more 
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analyses on the genes in the UPR need to be conducted to evaluate the UPR activities 
in CFTR WT and CFTR KO cells and thereby confirm or refute our conclusions.  
CFTR Deficiency in Caco2 Might Offer Protection Against Excessive ER Stress 
 
Although many cancer cells need high UPR to support them, excessive prolonged 
activation triggers a switch to an apoptotic pathway (Wang & Kaufman, 2016; 
Niederreiter, L. et al., 2013). To detect if the loss of CFTR protects the survival of CRC 
under hyperactivated irremediable ER stress, we compared cell viability of CFTR KO 
and WT cells under ER stress. The MTT assay was performed to determine the cell 
viability of CFTR KO and WT cells treated with TG to trigger ER stress. The initial 
step was to compare the cell viability of CFTR WT and CFTR KO Caco2 cell lines 
before TG treatment. The results showed that without TG treatment, CFTR WT cells 
had a slightly higher cell viability over the duration of plating (Figure 10). These data 
reflect the differences in cell growth between CFTR WT and CFTR KO cells and it 
occurred in all of our MTT experiments. 
After treatment, the cell viability changes after the induction of ER stress in CFTR 
WT and KO cells were determined with the use of the MTT assay. For analysis, MTT 
values at each point were normalized to 3h untreated controls for CFTR WT and CFTR 
KO cells to control the differences between plating. The result showed decreased cell 
viability after treatment in both CFTR WT and CFTR KO cells, which agreed with our 
expectation that TG induced ER stress might impair cell viability. To identify the effect 
of TG-induced ER stress on each cell line, the ratio of treated over untreated viability at 
each point was analyzed. The data showed a higher ratio in CFTR KO cells, indicating 
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that the loss of CFTR might cause TG-induced ER stress to have less of an effect on 
cell viability. These data agreed with our expectation that CFTR deficiency might 
relieve the effect of ER stress on viability. This suggests that the loss of CFTR might 
promote protection of colon cancer from excessive ER stress.  
To test the influence of CFTR deficiency, the cell viability changes in CFTR WT 
and KO cells after the induction of ER stress by another inducer, Tunicamycin (TM), 
was determined by conducting the MTT assay. The results showed declined cell 
viability after TM treatment in both CFTR WT and CFTR KO cells. This result agreed 
with our expectation that TM-induced ER stress might impair cell viability. To identify 
the effect of TM-induced ER stress on each cell line, the ratio of treated over untreated 
viability at each point was analyzed. The result showed that CFTR KO cells were less 
affected by TM treatment than WT cells. This indicates that the loss of CFTR might 
cause TM-induced ER stress to have less of an effect on cell viability. Only one 
biological replicate was evaluated in this experiment. More biological replicates and 
experiments are needed to confirm or refute this result. Both TG treatment and TM 
treatment experiments showed that the cell viability of CFTR KO cells was less 
impaired by ER stress than that of WT cells. These data agreed with our hypothesis that 
the loss of CFTR deficiency might protect the survival of CRC cells from excessive ER 
stress. 
The previous experiment showed decreased TXNIP expression in CFTR KO cells. 
Many studies reported that increased TXNIP expression levels lead to apoptosis 
(Oslowski et al., 2012; Lerner et al., 2012). Besides, a previous member of our lab, Dr. 
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Lei Zhao, showed the inhibiting role of TXNIP in cell viability in another CRC cell 
line, SW480 (Zhao, 2013). It is probable that the decreased TXNIP levels caused by 
CFTR deficiency relieves the effect of TXNIP on the initiation of apoptosis, and this 
relief might protect the survival of CRC cells. However, the experiments and analyses 
in this thesis are not enough to draw conclusions on this. More studies are required to 
test the correlation between CFTR, TXNIP and CRC cell survival.  
CFTR Deficiency in Caco2 Cell Lines Appeared to Restrict Activation of NF-κB in 
Response to UPR 
Grootjans et al. (2016) demonstrated that ER stress induced UPR triggers NF-κB 
activation. Recent research reported that CFTR deficiency activates the NF-κB 
signaling pathway (Crites et al., 2015). We hypothesized that CFTR deficiency might 
enhance NF-κB activation in the presence of UPR. To observe NF-κB activity in CFTR 
KO cells in response to UPR, RT-qPCR analysis was performed to compare the gene 
expression changes relating to the NF-κB signaling pathway in CFTR WT and CFTR 
KO Caco2 cell lines treated with TG to trigger ER stress. The result showed increased 
IL8 basal expression levels in CFTR KO cells, suggesting that CFTR deficiency might 
enhance the expression of the NF-κB target gene IL8. These data were consistent with 
microarray and IPA analyses in mice performed by Than et al. (2016). That study 
found the enrichment of gene sets involved in the immune response in Cftr- deficient 
tumors and normal tissues acquired from colons and small intestines. It is of interest to 
investigate the correlation between the NF-κB signaling pathway and CFTR in CRC. 
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The conclusion drawn from the mRNA expression of one gene is limited, and the 
results need to be confirmed by more studies.  
To determine the effect of TG treatment and induction of UPR on gene expression 
in CFTR WT and CFTR KO cells, the ratio of gene expression in treated cells over 
untreated cells was analyzed. The results showed increased expression of IL8 after 
treatment in both CFTR WT and CFTR KO cells, which agreed with our expectation 
that ER stress induced UPR might activate NF-κB signaling. The treatment had less of 
an effect on IL8 expression in CFTR KO. These data indicate that CFTR deficiency 
might cause TG to have less of an effect on IL8 expression. Instead, this result was not 
expected. We hypothesized that the loss of CFTR might enhance the activation of the 
NF-κB signaling pathway in response to UPR.  
Surprisingly, the result of RT-qPCR showed no difference between the TNF basal 
expression levels in CFTR WT and CFTR KO. This result is not consistent with our 
expectation that CFTR deficiency activates the NF-κB signaling pathway. It is possible 
that the mRNA stability of TNF might be low in CFTR KO and the low mRNA 
stability might negatively affect the expression level, because previous studies state that 
the expression of TNF mRNA is regulated at a transcriptional level and a 
posttranscriptional level including mRNA stability and polyadenylation (Szlosarek, et 
al., 2006; Anderson, 2000). 
After TG treatment, the results showed increased expression of TNF in both cell 
lines, which was consistent with our expectation that ER stress induced UPR might 
trigger NF-κB activation. The TG treatment had less of an effect on the expression of 
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TNF mRNA in CFTR KO cells. This suggests that defective CFTR might cause TG to 
have less of an effect on TNF expression. This result was not expected but similar to 
the effect of TG treatment on IL8 expression in CFTR KO cells. These data of IL8 and 
TNF mRNA expression consistently suggest that CFTR deficiency might cause TG to 
produce less of an effect on the expression of NF-κB signaling target genes IL8 and 
TNF. The data suggest that CFTR deficiency might cause TG-induced UPR to have less 
of an effect on NF-κB activation. In this experiment, we only tested mRNA expression 
levels of two genes relating to NF-κB, and the conclusions we can draw from this 
analysis are limited. The expression of other genes associated with NF-κB need to be 
tested in order to draw more precise and accurate conclusions in the future. Supervising 
the specific pathways through which UPR activates NF-κB signaling, like IRE1α and 
PERK, might help to explain why the TG treatment has less of an effect on the 
expression of TNF mRNA in CFTR KO. 
Vlantis et al. (2016) reported that enhanced activation of NF-κB in the intestinal 
epithelium promotes cell proliferation and offers a tumor-promoting 
microenvironment, contributing to the intestinal tumorigenesis. IL8 plays an important 
role in the recruitment of inflammatory cells and growth of colon carcinoma cell lines 
(Matsushima & Oppenheim, 1989; Brew et al., 1999). The enhanced expression of the 
NF-κB target gene IL8 in CFTR KO might suggest an increased activation of NF-κB 
signaling in CFTR KO and this activation might support the growth of cancer cells. The 
expression of other genes relating to NF-κB signaling needs to be tested in order to 
draw more precise and accurate conclusions in the future. 
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Conclusion and Future Directions 
 
Our data suggest that CFTR deficiency might enhance UPR activation even 
though the specific pathway might not be the one addressed in this study, and that the 
down regulation of TNXIP might offer protection for CRC cell survival. Considering 
the two possible roles of the UPR on CRC, one is that a higher level of UPR supports 
survival of some cancer cells (Corazzari, Gagliardi, Fimia & Piacentini, 2017); the 
other one is that increased UPR causes the differentiation of stem cells which could 
inhibit cancer development (Heijmans et al., 2013). Our data support the first 
possibility or suggest that the cancer supporting effect is stronger. Caco2 is a colon 
cancer cell line and it has a heterogeneous population of cancer cells. Its oncogenic 
potential is different from that of untransformed stem cells and thus, Caco2 might not 
be a good model to test if enhanced UPR activation suppresses cancer development 
through inducing the differentiation of stem cells. It is of interest to evaluate if CFTR 
deficiency activates UPR and if CFTR deficiency activated UPR supports CRC cell 
survival in models which have normal numbers of intestinal stem cells.  
Our data did not support our hypothesis that CFTR deficiency positively affects 
the NF-κB signaling pathway in the presence of UPR. It is of interest to perform more 
studies to characterize the relationship between CFTR and the NF-κB pathway in 
response to UPR in CRC. For example, the ER Stress TF Activation Profiling Plate 
Array can be utilized to simultaneously monitor ER stress and UPR related 
transcription factors, including NF-κB, ATF4, ATF6, CHOP, AP-1and p53. The data 
that enhanced basal expression levels of the NF-κB target gene IL8 in CFTR KO cells 
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might suggest an increased activation of NF-κB signaling in CFTR KO cells and this 
activation might support the growth of cancer cells.  
Considering the gene expression data and cell viability analysis data, we draw the 
conclusion that in Caco2 CRC cells CFTR deficiency may alter the response to UPR in 
several pathways, which may promote cancer cell survival. Additional experiments 
must be done to determine which ones among these altered pathways are vital for 
cancer development. Our data support our working model that UPR activation might be 
enhanced in CFTR KO, and this activation might protect CRC cell survival under ER 
stress. These data might contribute to investigating the relation between UPR and the 
cancer supporting effects of CFTR-deficiency. The findings of this thesis offer potential 
insights into the mechanism underlying CRC suppression by CFTR. This knowledge 
might help in therapies for CRC. 
There are limitations in this study, and more studies need to be conducted to 
completely support our hypothesis. In the future, mRNA expression and protein 
expression levels of more genes involved in the three UPR sub-pathways and NF-κB 
signaling should be evaluated. Different types of inducers should be used to evaluate 
cell viability in the presence of ER stress in combination with varying nutrition 
conditions. Other colon cancer cell lines, normal colon cell lines and tissue culture 
methods are suggested to be used in order to examine the relation between CFTR 
deficiency and UPR activation and their effects on CRC. More biological replicates are 
required, and these data might confirm our working model.  
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Material and Methods 
Cell Culture and Treatment  
CFTR WT and CFTR KO Caco2 cell lines were provided by Mitchell Drumm from 
Case Western Reserve University and cultured in a culture medium composed of 
EMEM (Mediatech, 639688), 10% fetal bovine serum (FBS) and L- Glutamine 
(Mediatech, 21716002). The cells were cultured in 100mm tissue culture dishes at 37°C 
in a humidified atmosphere of 5% CO2.  
To compare the mRNA expression of genes in CFTR WT cells and CFTR KO 
cells, total RNA was extracted from CFTR WT and CFTR KO Caco2 cells. One million 
(106) cells were plated in 100mm tissue culture dishes and grown for 18 hours at 37°C. 
RT-qPCR was conducted to test mRNA expression levels.  
For the Thapsigargin (TG) treatment study, the cells were grown in EMEM and put 
into four groups: the CFTR WT cells control group, incubation with 0.1% DMSO; the 
CFTR WT cells treatment group, incubation with 0.2 µM TG; the CFTR KO cells 
control group, incubation with 0.1% DMSO; the CFTR KO cells treatment group, 
incubation with 0.2 µM TG. To prepare for RNA extraction, one million (106) cells 
were plated in 100 mm tissue culture dishes and grown for 18 hours at 37°C before 
treatment. Cells were treated with 0.2 µM TG for 2.5 hours, then RNA were acquired. 
RT-qPCR was conducted to test mRNA expression levels.  
To compare cell viability of CFTR WT and CFTR KO Caco2 cell lines, cells were 
prepared for the MTT assay. Twenty-five hundred (2,500) Caco2 cells per well, 5,000 
Caco2 cells per well, and 10,000 Caco2 cells per well with 6 technical replicates were 
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plated into a 96-well plate and cultured from 18 hours to 90 hours in 1 biological 
replicate. The MTT assay was conducted to test cell viability. 
For the dose gradient of the TG treatment study, cells were prepared for MTT 
assay. Ten thousand (10,000) Caco2 cells per well with 6 technical replicates were 
plated into a 96-well plate and grown for 18 hours at 37°C before treatment. The cells 
were treated with the TG with different doses (0.2 µM, 0.4 µM, 0.8 µM) over time, at 2 
hours, 24 hours, 48 hours, and 72 hours in 1 biological replicate. The MTT assay was 
conducted to test cell viability after the TG treatment at the same intervals. 
To compare cell viability of CFTR WT and CFTR KO Caco2 cell lines under ER 
stress, cells were prepared for the MTT assay. Five thousand (5,000) Caco2 cells per 
well with 6 technical replicates were plated into a 96-well plate and grown for 18 hours 
at 37°C before treatment. The cells were treated with the 0.2 µM TG over time, at 3 
hours, 24 hours, 48 hours, and 72 hours in 3 biological replicates. The MTT assay was 
conducted to test cell viability after the TG treatment at the same intervals.  
For the Tunicamycin (TM) treatment study, the cells were grown in EMEM and 
put into four groups: the CFTR WT cells control group, incubation with 0.1% DMSO; 
the CFTR WT cells treatment group, incubation with 2.5 µg/ml TM, incubation with 5 
µg/ml TM, incubation with 10 µg/ml TM; the CFTR KO cells control group, 
incubation with 0.1% DMSO; the CFTR KO cells treatment group, incubation with 2.5 
µg/ml TM, incubation with 5 µg/ml TM, incubation with 10 µg/ml TM. To compare 
cell viability of CFTR WT and CFTR KO Caco2 cell lines under ER stress, cells were 
prepared for the MTT assay. Twenty thousand (20,000) Caco2 cells per well with 6 
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technical replicates were plated into a 96-well plate, and grown for 18 h at 37°C before 
treatment. The cells were treated with the TM with different doses (2.5 µg/ml, 5 µg/ml, 
10 µg/ml) over time, at 2 hours, 24 hours, 48 hours, and 72 hours in 1 biological 
replicate. The MTT assay was conducted to test cell viability after the TM treatment at 
the same intervals. 
RNA Extraction 
Total cellular RNA was isolated using a Qiagen RNeasy Mini Kit (Qiagen, 
Hilden, Germany), according to the manufacturer's recommendations. RNA 
concentration was calculated based on the absorbance at 260nm. RNA samples were 
stored at −20°C. 
Quantitative Reverse Transcriptase Polymerase Chain Reaction (RT- qPCR) 
The standard cDNA was reverse-transcribed from 1.5µg of total RNA from the 
T84 colon cancer cell line using a Qiagen Omniscript RT Kit (cat. No. 205113) and the 
specific primer.  
The total cDNA was reverse-transcribed from 1.5 µg of total RNA from CFTR 
WT and CFTR KO Caco2 cell lines using a Qiagen Omniscript RT Kit (cat. No. 
205113) and Random Primer 9.  
Quantitative polymerase chain reaction (qPCR) monitors the amplification of 
target DNA during the PCR in real-time using fluorescent dyes which bind non-
specifically to double stranded DNA. The PCR products can be detected by 
measurement of SYBR Green I fluorescence signals. SYBR Green I binds to the double 
stranded DNA helix. The SYBR Green I fluorescence signal is proportional to the 
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amount of double-stranded DNA produced by PCR. The computer linked to the Roche 
Light Cycler 480 Real-Time PCR Instrument would produce an amplification curve 
which displays the fluorescence values versus cycle number. The threshold of the 
amplification curve reflects a significant increase over the initial cycles of PCR. The 
cycle number at which the fluorescent signal of the reaction crosses the threshold is 
defined as threshold cycle (Ct), which is used to calculate the initial DNA copy 
number, because the Ct value is inversely related to the starting amount of a sample. 
The 5-point, 10-fold serial dilution of the target standard would have 5 curves on a plot 
and thus have 5 Ct values. Then the computer would generate a standard curve which 
reflects the relationship between the starting quantity (X axis) which is already known 
and Ct values (Y axis) for each target gene or 18S. To measure the level of expression 
of a gene in a new sample, qPCR was performed to this sample and standards. The 
sample will have a Ct value after amplification, and the starting quantity of the sample 
will be calculated by comparison with the standard curve for each target gene or 18S.  
The standard cDNA was amplified with the use of the Qiagen HotStarTaq Master 
Mix Kit (cat. No. 203443) and then purified with the use of the Qiagen MinElute PCR 
Purification Kit (cat. No. 28004). The concentration of purified amplified cDNA was 
determined by using the Nanodrop 2000 spectrophotometer (NanoDrop, 
ThermoScientific). After calculation, the purified amplified cDNA was diluted to a 
standard stock at 5E9 copies/µl in order to prepare a 5-point, 10-fold serial dilution of 
the target standard. A 5-point standard curve was set up: E7 copies/µl to E2 copies/µl.  
The total cDNA was amplified with the use of the Qiagen HotStarTaq Master Mix 
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Kit (cat. No. 203443). The 1: 10 dilutions of concentrated cDNA and 1: 100 dilutions 
of concentrated cDNA were prepared. A standard curve composed of ten-fold serial 
dilutions of concentrated cDNA was included in each qPCR run for each specific target 
primer. A standard curve composed of 1: 100 dilutions of concentrated cDNA was 
included in each qPCR run for the 18S primer. The input of 15 ng total cDNA in 
duplicate per sample was used for each specific target primer pair, and the input of 1.5 
ng cDNA in duplicate per sample was used for each 18S primer pair. The expression 
level of each target gene or 18S in cDNA was calculated based on the standard curve of 
PCR amplification for each target gene or 18S. Reactions were performed with the use 
of a SYBR Green I Master Kit and 10 µM of each primer per reaction in a total volume 
of 20 µl on the Roche Light Cycler 480 Real-Time PCR Instrument. The reactions 
include: pre-incubation at 95°C for five minutes in one cycle; amplification- 45 cycles, 
95°C for five seconds, 60°C for five seconds, and 72°C for ten seconds; melting curve- 
1cycle, 95°C for five seconds, 65°C for one minute, and 97°C in continuous mode; 
cooling- 1 cycle, until 40°C for thirty seconds. Expression of each specific target gene 
was normalized to 18S and expressed as a fold induction.  
List of primers used  
All primers were designed using Primer-BLAST (National Center for 
Biotechnology Information) and obtained from Integrated DNA Technologies 
(Coralville, IA, USA).  
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Gene  Primer   Sequence (5’- 3’) 
 
XBP1  Forward primer GGGGAATGAAGTGAGGCCAG 
Reverse primer TTGTCCAGAATGCCCAACAGG 
 
TXNIP  Forward primer TTCGGAGTACCTGCGCTATG 
   Reverse primer AGGAAGCTCAAAGCCGAACT 
 
ATF4  Forward primer AGGAGGAAGACACCCCTTCA 
Reverse primer ATCGTAAGGTTTGGGACGGG 
 
        HSPA5  Forward primer GAACGTCTGATTGGCGATGC 
Reverse primer TCAACCACCTTGAACGGCAA 
 
CFTR                   Forward primer  GACATCACAGCAGGTCAGAGAA  
                     Reverse primer CAACGCTGGCCTTTTCCAGA 
 
18S  Forward primer CGCCGCTAGAGGTGAAATTCTT 
Reverse primer CAGTCGGCATCGTTTATGGTC 
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IL8  Forward primer ACCGGAAGGAACCATCTCAC 
Reverse primer AAACTGCACCTTCACACAGAG 
 
TNF  Forward primer GCTGCACTTTGGAGTGATCG 
Reverse primer GAGGGTTTGCTACAACATGGG 
 
 
MTT Assay  
The MTT assay is a colorimetric assay that measures the conversion of the yellow 
color MTT into purple formazan via the mitochondrial enzyme succinate 
dehydrogenase in live cells (Mosmann, 1983). The prepared cells were grown in 
EMEM and incubated with 0.1% DMSO or treated with ER stress inducers over time. 
Then the medium was replaced with EMEM and supplemented with 0.5 mg/ml MTT 
Reagent. After 4 hours of incubation, the purple formazan crystals within the live cells 
were dissolved in 100 µl SDS in each well. The extent of color conversion is 
quantitated by measuring absorbance in a plate reader at wavelength of 590 nm. Wells 
without cells were used as blanks and were subtracted as background from each 
sample.  
Statistical Analysis 
All quantitative results are given as averages with standard deviation unless 
otherwise stated. A paired two-tailed t-test was used to determine the statistical 
significance of the entirety of the RT-qPCR data and MTT data in this thesis. All 
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statistical tests used a significance value of α = 0.05. Comparisons of p ≤ 0.05 are 
marked by an asterisk *. The p values are not shown in the results when p > 0.05. 
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